Loading…
Partial Nephrectomy for T1b/T2 Renal Mass: An Added Shift from Radical Nephrectomy
The aim of our study was to show our short-term experience in managing large renal masses (cT1b/T2) through partial nephrectomy (PN) over the last 3 years. Retrospective data collection for all patients managed by PN for renal masses larger than 4 cm over the last 3 years. Epidemiological data were...
Saved in:
Published in: | Journal of kidney cancer and VHL 2022-10, Vol.9 (4), p.1-5 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 5 |
container_issue | 4 |
container_start_page | 1 |
container_title | Journal of kidney cancer and VHL |
container_volume | 9 |
creator | Sharafeldeen, Mohamed Sameh, Wael Mehrnoush, Vahid Alaref, Amer Rozenberg, Radu Ismail, Asmaa Elmansy, Hazem Shahrour, Walid Zakaria, Ahmed Elmeslemany, Osama Burute, Nishigandha Shuster, Anatoly Prowse, Owen Kotb, Ahmed |
description | The aim of our study was to show our short-term experience in managing large renal masses (cT1b/T2) through partial nephrectomy (PN) over the last 3 years. Retrospective data collection for all patients managed by PN for renal masses larger than 4 cm over the last 3 years. Epidemiological data were collected. Surgical data including surgical and ischemic times as well as intra and postoperative complications were collected. Pre- and postoperative estimated glomerular filtration rate (eGFR) data were collected and correlated as well as postoperative complications and recurrence. We could identify 47 patients managed by PN for radiologically confirmed >4 cm renal masses. The mean age of the patients was 55.7 ± 13.4, including 29 males and 18 females. Masses were T1b and T2 in 40 and 7 patients, respectively. The mean tumor size was 6.2 ± 1.5 cm. Using renal nephrometry score; 8, 28, and 11 had low, moderate, and high complexity, respectively. Renal cell carcinoma (RCC) was identified in 42 patients. Five patients out of 42 cancerous cases (12%) had pathological T3 RCC. The mean preoperative and postoperative eGFR were 89.09 ± 12.41 and 88.50 ± 10.50, respectively (P 0.2). The median follow-up was 14 months and within that short time, no patient had evidence for cancer recurrence. PN for large renal masses is safe in experienced hands and should be attempted in a higher percentage of patients, regardless of the tumor complexity. No cancer recurrence or deterioration of renal function was observed within our short-term follow-up. |
doi_str_mv | 10.15586/jkcvhl.v9i4.255 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9550639</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2730648226</sourcerecordid><originalsourceid>FETCH-LOGICAL-c214t-852281e73ac9462897b2081fa5e96bce586ef33c147dc81f4ca05ced7d3538703</originalsourceid><addsrcrecordid>eNpVkEtPwzAQhC0EElXpnWOOcEi7tmPHuSChipdUHkLlbDnOhqYkcbGTSv33BFohOO1qZzQ7-gg5pzClQig5W3_Y7aqebrMqmTIhjsiIMeCxUEwe_9lPySSENQBQkUlQMCKXL8Z3lamjJ9ysPNrONbuodD5a0ny2ZNErtoP4aEI4IyelqQNODnNM3m5vlvP7ePF89zC_XsSW0aSLlWBMUUy5sVkimcrSnIGipRGYydzi0BZLzi1N0sIO98QaEBaLtOCCqxT4mFztczd93mBhse28qfXGV43xO-1Mpf8rbbXS726rMyFA8mwIuDgEePfZY-h0UwWLdW1adH3QLOUgE8WYHKywt1rvQvBY_r6hoH_I6j1Z_U1WD2T5FybobTQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2730648226</pqid></control><display><type>article</type><title>Partial Nephrectomy for T1b/T2 Renal Mass: An Added Shift from Radical Nephrectomy</title><source>PubMed Central Free</source><source>Publicly Available Content Database</source><creator>Sharafeldeen, Mohamed ; Sameh, Wael ; Mehrnoush, Vahid ; Alaref, Amer ; Rozenberg, Radu ; Ismail, Asmaa ; Elmansy, Hazem ; Shahrour, Walid ; Zakaria, Ahmed ; Elmeslemany, Osama ; Burute, Nishigandha ; Shuster, Anatoly ; Prowse, Owen ; Kotb, Ahmed</creator><creatorcontrib>Sharafeldeen, Mohamed ; Sameh, Wael ; Mehrnoush, Vahid ; Alaref, Amer ; Rozenberg, Radu ; Ismail, Asmaa ; Elmansy, Hazem ; Shahrour, Walid ; Zakaria, Ahmed ; Elmeslemany, Osama ; Burute, Nishigandha ; Shuster, Anatoly ; Prowse, Owen ; Kotb, Ahmed</creatorcontrib><description>The aim of our study was to show our short-term experience in managing large renal masses (cT1b/T2) through partial nephrectomy (PN) over the last 3 years. Retrospective data collection for all patients managed by PN for renal masses larger than 4 cm over the last 3 years. Epidemiological data were collected. Surgical data including surgical and ischemic times as well as intra and postoperative complications were collected. Pre- and postoperative estimated glomerular filtration rate (eGFR) data were collected and correlated as well as postoperative complications and recurrence. We could identify 47 patients managed by PN for radiologically confirmed >4 cm renal masses. The mean age of the patients was 55.7 ± 13.4, including 29 males and 18 females. Masses were T1b and T2 in 40 and 7 patients, respectively. The mean tumor size was 6.2 ± 1.5 cm. Using renal nephrometry score; 8, 28, and 11 had low, moderate, and high complexity, respectively. Renal cell carcinoma (RCC) was identified in 42 patients. Five patients out of 42 cancerous cases (12%) had pathological T3 RCC. The mean preoperative and postoperative eGFR were 89.09 ± 12.41 and 88.50 ± 10.50, respectively (P 0.2). The median follow-up was 14 months and within that short time, no patient had evidence for cancer recurrence. PN for large renal masses is safe in experienced hands and should be attempted in a higher percentage of patients, regardless of the tumor complexity. No cancer recurrence or deterioration of renal function was observed within our short-term follow-up.</description><identifier>ISSN: 2203-5826</identifier><identifier>EISSN: 2203-5826</identifier><identifier>DOI: 10.15586/jkcvhl.v9i4.255</identifier><language>eng</language><publisher>Codon Publications</publisher><subject>Kidney Cancer: Original</subject><ispartof>Journal of kidney cancer and VHL, 2022-10, Vol.9 (4), p.1-5</ispartof><rights>Sharafeldeen M, et al. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550639/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550639/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,37013,53791,53793</link.rule.ids></links><search><creatorcontrib>Sharafeldeen, Mohamed</creatorcontrib><creatorcontrib>Sameh, Wael</creatorcontrib><creatorcontrib>Mehrnoush, Vahid</creatorcontrib><creatorcontrib>Alaref, Amer</creatorcontrib><creatorcontrib>Rozenberg, Radu</creatorcontrib><creatorcontrib>Ismail, Asmaa</creatorcontrib><creatorcontrib>Elmansy, Hazem</creatorcontrib><creatorcontrib>Shahrour, Walid</creatorcontrib><creatorcontrib>Zakaria, Ahmed</creatorcontrib><creatorcontrib>Elmeslemany, Osama</creatorcontrib><creatorcontrib>Burute, Nishigandha</creatorcontrib><creatorcontrib>Shuster, Anatoly</creatorcontrib><creatorcontrib>Prowse, Owen</creatorcontrib><creatorcontrib>Kotb, Ahmed</creatorcontrib><title>Partial Nephrectomy for T1b/T2 Renal Mass: An Added Shift from Radical Nephrectomy</title><title>Journal of kidney cancer and VHL</title><description>The aim of our study was to show our short-term experience in managing large renal masses (cT1b/T2) through partial nephrectomy (PN) over the last 3 years. Retrospective data collection for all patients managed by PN for renal masses larger than 4 cm over the last 3 years. Epidemiological data were collected. Surgical data including surgical and ischemic times as well as intra and postoperative complications were collected. Pre- and postoperative estimated glomerular filtration rate (eGFR) data were collected and correlated as well as postoperative complications and recurrence. We could identify 47 patients managed by PN for radiologically confirmed >4 cm renal masses. The mean age of the patients was 55.7 ± 13.4, including 29 males and 18 females. Masses were T1b and T2 in 40 and 7 patients, respectively. The mean tumor size was 6.2 ± 1.5 cm. Using renal nephrometry score; 8, 28, and 11 had low, moderate, and high complexity, respectively. Renal cell carcinoma (RCC) was identified in 42 patients. Five patients out of 42 cancerous cases (12%) had pathological T3 RCC. The mean preoperative and postoperative eGFR were 89.09 ± 12.41 and 88.50 ± 10.50, respectively (P 0.2). The median follow-up was 14 months and within that short time, no patient had evidence for cancer recurrence. PN for large renal masses is safe in experienced hands and should be attempted in a higher percentage of patients, regardless of the tumor complexity. No cancer recurrence or deterioration of renal function was observed within our short-term follow-up.</description><subject>Kidney Cancer: Original</subject><issn>2203-5826</issn><issn>2203-5826</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpVkEtPwzAQhC0EElXpnWOOcEi7tmPHuSChipdUHkLlbDnOhqYkcbGTSv33BFohOO1qZzQ7-gg5pzClQig5W3_Y7aqebrMqmTIhjsiIMeCxUEwe_9lPySSENQBQkUlQMCKXL8Z3lamjJ9ysPNrONbuodD5a0ny2ZNErtoP4aEI4IyelqQNODnNM3m5vlvP7ePF89zC_XsSW0aSLlWBMUUy5sVkimcrSnIGipRGYydzi0BZLzi1N0sIO98QaEBaLtOCCqxT4mFztczd93mBhse28qfXGV43xO-1Mpf8rbbXS726rMyFA8mwIuDgEePfZY-h0UwWLdW1adH3QLOUgE8WYHKywt1rvQvBY_r6hoH_I6j1Z_U1WD2T5FybobTQ</recordid><startdate>20221006</startdate><enddate>20221006</enddate><creator>Sharafeldeen, Mohamed</creator><creator>Sameh, Wael</creator><creator>Mehrnoush, Vahid</creator><creator>Alaref, Amer</creator><creator>Rozenberg, Radu</creator><creator>Ismail, Asmaa</creator><creator>Elmansy, Hazem</creator><creator>Shahrour, Walid</creator><creator>Zakaria, Ahmed</creator><creator>Elmeslemany, Osama</creator><creator>Burute, Nishigandha</creator><creator>Shuster, Anatoly</creator><creator>Prowse, Owen</creator><creator>Kotb, Ahmed</creator><general>Codon Publications</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20221006</creationdate><title>Partial Nephrectomy for T1b/T2 Renal Mass</title><author>Sharafeldeen, Mohamed ; Sameh, Wael ; Mehrnoush, Vahid ; Alaref, Amer ; Rozenberg, Radu ; Ismail, Asmaa ; Elmansy, Hazem ; Shahrour, Walid ; Zakaria, Ahmed ; Elmeslemany, Osama ; Burute, Nishigandha ; Shuster, Anatoly ; Prowse, Owen ; Kotb, Ahmed</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c214t-852281e73ac9462897b2081fa5e96bce586ef33c147dc81f4ca05ced7d3538703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Kidney Cancer: Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sharafeldeen, Mohamed</creatorcontrib><creatorcontrib>Sameh, Wael</creatorcontrib><creatorcontrib>Mehrnoush, Vahid</creatorcontrib><creatorcontrib>Alaref, Amer</creatorcontrib><creatorcontrib>Rozenberg, Radu</creatorcontrib><creatorcontrib>Ismail, Asmaa</creatorcontrib><creatorcontrib>Elmansy, Hazem</creatorcontrib><creatorcontrib>Shahrour, Walid</creatorcontrib><creatorcontrib>Zakaria, Ahmed</creatorcontrib><creatorcontrib>Elmeslemany, Osama</creatorcontrib><creatorcontrib>Burute, Nishigandha</creatorcontrib><creatorcontrib>Shuster, Anatoly</creatorcontrib><creatorcontrib>Prowse, Owen</creatorcontrib><creatorcontrib>Kotb, Ahmed</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of kidney cancer and VHL</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sharafeldeen, Mohamed</au><au>Sameh, Wael</au><au>Mehrnoush, Vahid</au><au>Alaref, Amer</au><au>Rozenberg, Radu</au><au>Ismail, Asmaa</au><au>Elmansy, Hazem</au><au>Shahrour, Walid</au><au>Zakaria, Ahmed</au><au>Elmeslemany, Osama</au><au>Burute, Nishigandha</au><au>Shuster, Anatoly</au><au>Prowse, Owen</au><au>Kotb, Ahmed</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Partial Nephrectomy for T1b/T2 Renal Mass: An Added Shift from Radical Nephrectomy</atitle><jtitle>Journal of kidney cancer and VHL</jtitle><date>2022-10-06</date><risdate>2022</risdate><volume>9</volume><issue>4</issue><spage>1</spage><epage>5</epage><pages>1-5</pages><issn>2203-5826</issn><eissn>2203-5826</eissn><abstract>The aim of our study was to show our short-term experience in managing large renal masses (cT1b/T2) through partial nephrectomy (PN) over the last 3 years. Retrospective data collection for all patients managed by PN for renal masses larger than 4 cm over the last 3 years. Epidemiological data were collected. Surgical data including surgical and ischemic times as well as intra and postoperative complications were collected. Pre- and postoperative estimated glomerular filtration rate (eGFR) data were collected and correlated as well as postoperative complications and recurrence. We could identify 47 patients managed by PN for radiologically confirmed >4 cm renal masses. The mean age of the patients was 55.7 ± 13.4, including 29 males and 18 females. Masses were T1b and T2 in 40 and 7 patients, respectively. The mean tumor size was 6.2 ± 1.5 cm. Using renal nephrometry score; 8, 28, and 11 had low, moderate, and high complexity, respectively. Renal cell carcinoma (RCC) was identified in 42 patients. Five patients out of 42 cancerous cases (12%) had pathological T3 RCC. The mean preoperative and postoperative eGFR were 89.09 ± 12.41 and 88.50 ± 10.50, respectively (P 0.2). The median follow-up was 14 months and within that short time, no patient had evidence for cancer recurrence. PN for large renal masses is safe in experienced hands and should be attempted in a higher percentage of patients, regardless of the tumor complexity. No cancer recurrence or deterioration of renal function was observed within our short-term follow-up.</abstract><pub>Codon Publications</pub><doi>10.15586/jkcvhl.v9i4.255</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2203-5826 |
ispartof | Journal of kidney cancer and VHL, 2022-10, Vol.9 (4), p.1-5 |
issn | 2203-5826 2203-5826 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9550639 |
source | PubMed Central Free; Publicly Available Content Database |
subjects | Kidney Cancer: Original |
title | Partial Nephrectomy for T1b/T2 Renal Mass: An Added Shift from Radical Nephrectomy |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A58%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Partial%20Nephrectomy%20for%20T1b/T2%20Renal%20Mass:%20An%20Added%20Shift%20from%20Radical%20Nephrectomy&rft.jtitle=Journal%20of%20kidney%20cancer%20and%20VHL&rft.au=Sharafeldeen,%20Mohamed&rft.date=2022-10-06&rft.volume=9&rft.issue=4&rft.spage=1&rft.epage=5&rft.pages=1-5&rft.issn=2203-5826&rft.eissn=2203-5826&rft_id=info:doi/10.15586/jkcvhl.v9i4.255&rft_dat=%3Cproquest_pubme%3E2730648226%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c214t-852281e73ac9462897b2081fa5e96bce586ef33c147dc81f4ca05ced7d3538703%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2730648226&rft_id=info:pmid/&rfr_iscdi=true |